Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Lee

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Acta Dermato-Venereologica|March 21, 2015
Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMRAbdul Wali, Lu Liu, Takuya Takeichi, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 25, 2020
Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI)Guy Todd Alonso, Sarah Corathers, Anvi Shah, et al.
Diabetes Care|August 11, 2010
Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial, Roy W Beck, Jean M Lawrence, et al.
Journal of Hematology & Oncology|June 12, 2019
High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancerWenwu Xiao, Weijie Ma, Sixi Wei, et al.
Journal of Hematology & Oncology|July 28, 2019
Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancerWenwu Xiao, Weijie Ma, Sixi Wei, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 23, 2020
Erratum. Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Clinical Diabetes 2020;38:141-151 (DOI: 10.2337/cd19-0032)Guy Todd Alonso, Sarah Corathers, Avni Shah, et al.
Asia Pacific Allergy|June 30, 2023
Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicityXin Rong Lim, Yi Wye Lai, Choon Guan Chua, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Cancers|January 23, 2024
Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute LeukemiaDarren Finlay, Rabi Murad, Karl Hong, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Acta Dermato-Venereologica|March 21, 2015
Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMRAbdul Wali, Lu Liu, Takuya Takeichi, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 25, 2020
Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI)Guy Todd Alonso, Sarah Corathers, Anvi Shah, et al.
Diabetes Care|August 11, 2010
Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial, Roy W Beck, Jean M Lawrence, et al.
Journal of Hematology & Oncology|June 12, 2019
High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancerWenwu Xiao, Weijie Ma, Sixi Wei, et al.
Journal of Hematology & Oncology|July 28, 2019
Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancerWenwu Xiao, Weijie Ma, Sixi Wei, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 23, 2020
Erratum. Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Clinical Diabetes 2020;38:141-151 (DOI: 10.2337/cd19-0032)Guy Todd Alonso, Sarah Corathers, Avni Shah, et al.
Asia Pacific Allergy|June 30, 2023
Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicityXin Rong Lim, Yi Wye Lai, Choon Guan Chua, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Cancers|January 23, 2024
Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute LeukemiaDarren Finlay, Rabi Murad, Karl Hong, et al.
Pageof 20